The company's software system is designed to streamline the work done by staff at clinical trial sites, such as manually copying information about patient recruitment and enrollment.
Asset Management Ventures, a Silicon Valley-based health tech investment firm, is raising $150 million for a new fund, according to financial documents.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The San Francisco-based company plans to use the money primarily to fund its ongoing Phase II study of the drug, which it initiated in May.
Thiel and Parker were part of a more than $12 million funding round for the stealth immunotherapy business,
So far, attempts to reach HealthSpot CEO Steve Cashman have been unsuccessful, so we haven't heard the company's explanation for why it failed. It's left to others to speculate.
But don't get too excited about on-demand house calls.
At the Abarca Forward conference earlier this year, George Van Antwerp, managing director at Deloitte, discussed how social determinants of health and a personalized member experience can improve medication adherence and health outcomes.